SASB content index
|
SASB code |
|
Metric description |
|
Level of disclosure |
|
Main reference |
|
|
External assurance |
|
HC-MS-240a.1 |
|
Ratio of weighted average rate of net price increases (for all products) to the annual increase in the U.S. Consumer Price Index |
|
Omission 1 |
|
|
|
|
No |
|
HC-MS-240a.2 |
|
Description of how price information for each product is disclosed to customers or to their agents |
|
Partial |
|
Ethical marketing and sales practices |
https://report.sonova.com/2022/en/?p=14024#ethical-marketing-and-sales-practices |
|
No |
|
HC-MS-250a.1 |
|
Number of recalls issued, total units recalled |
|
Full |
|
Product quality, safety and reliability |
https://report.sonova.com/2022/en/?p=14024#product-reliability-global-targets |
|
No |
|
HC-MS-250a.2 |
|
List of products listed in the FDA’s MedWatch Safety Alerts for Human Medical Products database |
|
Full |
|
Product quality, safety and reliability |
https://report.sonova.com/2022/en/?p=14024#product-quality-and-safety-management |
|
No |
|
HC-MS-250a.3 |
|
Number of fatalities related to products as reported in the FDA Manufacturer and User Facility Device Experience |
|
Full |
|
Product quality, safety and reliability |
https://report.sonova.com/2022/en/?p=14024#product-quality-and-safety-management |
|
No |
|
HC-MS-250a.4 |
|
Number of FDA enforcement actions taken in response to violations of current Good Manufacturing Practices (cGMP), by type |
|
Full |
|
Product quality, safety and reliability |
https://report.sonova.com/2022/en/?p=14024#product-quality-and-safety-management |
|
No |
|
HC-MS-270a.1 |
|
Total amount of monetary losses as a result of legal proceedings associated with false marketing claims |
|
Full |
|
Ethical marketing and sales practices |
https://report.sonova.com/2022/en/?p=14024#ethical-marketing-and-sales-practices |
|
No |
|
HC-MS-270a.2 |
|
Description of code of ethics governing promotion of off-label use of products |
|
Omission 2 |
|
|
|
|
No |
|
HC-MS-410a.1 |
|
Discussion of process to assess and manage environmental and human health considerations associated with chemicals in products, and meet demand for sustainable products |
|
Full |
|
Eco-friendly products |
https://report.sonova.com/2022/en/?p=13722#product-materials |
|
No |
|
HC-MS-410a.2 |
|
Total amount of products accepted for takeback and reused, recycled, or donated, broken down by: (1) devices and equipment and (2) supplies |
|
Partial |
|
Eco-friendly products |
https://report.sonova.com/2022/en/?p=13722#product-end-of-life |
|
No |
|
HC-MS-430a.1 |
|
Percentage of (1) entity’s facilities and (2) Tier I suppliers’ facilities participating in third-party audit programs for manufacturing and product quality |
|
Full |
|
Product quality, safety and reliability |
https://report.sonova.com/2022/en/?p=14024#product-quality-and-safety-management |
|
No |
|
HC-MS-430a.2 |
|
Description of efforts to maintain traceability within the distribution chain |
|
Partial |
|
Product quality, safety and reliability |
https://report.sonova.com/2022/en/?p=14024#product-quality-and-safety-management |
|
No |
|
HC-MS-430a.3 |
|
Description of the management of risks associated with the use of critical materials |
|
Partial |
|
Responsible supply chain |
https://report.sonova.com/2022/en/?p=14024#responsible-supply-chain |
|
No |
|
HC-MS-510a.1 |
|
Total amount of monetary losses as a result of legal proceedings associated with bribery or corruption |
|
Full |
|
Business ethics and legal compliance |
https://report.sonova.com/2022/en/?p=14024#corruption-and-bribery |
|
No |
|
HC-MS-510a.2 |
|
Description of code of ethics governing interactions with health care professionals |
|
Full |
|
Ethical marketing and sales practices |
https://report.sonova.com/2022/en/?p=14024#ethical-marketing-and-sales-practices |
|
No |
|
HC-MS-000.A |
|
Number of units sold by product category |
|
Adjusted 3 |
|
|
|
|
No |
UNGC = UN Global Compact Principle.
SDG = UN Sustainable Development Goal.
1 Sonova does not report detailed price information on all its products in its investor reporting. However, information related to the pricing strategy is reported in the Annual Report (Strategy and businesses, compensation report, financial review).
2 This metric is not applicable to Sonova’s business model.
3 Sonova instead reports the sales volumes by business segment (Annual Report: Notes to the consolidated financial statements – 2.2 Segment information).
